Frontline Ltd (FRO) Moves Lower on Volume Spike for November 27

Equities Staff  |

Frontline Ltd (FRO) traded on unusually high volume on Nov. 27, as the stock lost 2.5% to close at $5.45. On the day, Frontline Ltd saw 675,463 shares trade hands on 4,014 trades. Considering that the stock averages only a daily volume of 436,344 shares a day over the last month, this represents a pretty significant bump in volume over the norm.

Generally speaking, when a stock experiences a sudden spike in trading volume, it may be seen as a bullish signal for investors. An increase in volume means more market awareness for the company, potentially setting up a more meaningful move in stock price. The added volume also provides a level of support and stability for price advances.

The stock has traded between $7.83 and $4.87 over the last 52-weeks, its 50-day SMA is now $5.98, and its 200-day SMA $6.02. Frontline Ltd has a P/B ratio of 0.63. It also has a P/E ratio of 29.4.

Frontline Ltd is an oil tanker shipping firm. The company operates a fleet of crude oil tankers that transports crude oil internationally under short- and medium-term contracts. Some of the vessels also transport raw materials such as iron ore and coal.

Headquartered in Hamilton, , Frontline Ltd has 135 employees and is currently under the leadership of CEO John Fredriksen.

For a complete fundamental analysis analysis of Frontline Ltd, check out Equities.com’s Stock Valuation Analysis report for FRO.

Want to invest with the experts? Subscribe to Equities Premium newsletters today! Visit http://www.equitiespremium.com/ to learn more about Guild Investment’s Market Commentary and Adam Sarhan’s Find Leading Stocks today.

To get more information on Frontline Ltd and to follow the company’s latest updates, you can visit the company’s profile page here: FRO’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments


Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     
BA

     
WMT

     
DIS

     
XOM

     

World Economic Forum at Davos 2019 - Kitty Parry CEO DeepView

Matt Bird sits down with Kitty Parry, CEO DeepView, at the World Economic Forum at Davos 2019

Emerging Growth

Q BioMed Inc

Q BioMed Inc is a biomedical acceleration and development company. The company is a biomedical acceleration and development company focused on licensing, acquiring and providing strategic resources to life sciences…